Sculptor1 wrote: ↑April 21st, 2023, 5:37 amAs citizens, we need to be proactive in educating ourselves about the various factors that influence public health, nutrition, and the healthcare system. By staying informed, we can make better choices for ourselves and our communities. This involves reading up on research, understanding the role of corporations and their financial interests, and recognizing the potential biases in guidelines and recommendations put forth by organizations.Sushan wrote: ↑April 21st, 2023, 12:45 amI think all you would really have to do is make it a felony for any politician to take money from outside interests, and a capital crime to fail to disclose any interests.Sculptor1 wrote: ↑April 13th, 2023, 6:54 amYou've brought up several important points about the influence of pharmaceutical and food industries on healthcare, research, and public policy. It's true that these industries often prioritize profit over public health, which can lead to biased research, misleading guidelines, and the promotion of products and treatments that may not be in the best interest of patients.Sushan wrote: ↑April 13th, 2023, 3:05 amNo there is no real interest there. What they want is to prolong treatments so they can keep selling drugs. Actually curing the disease is not within the remit of the vast majority of drugs.
While acknowledging the role of pharmaceutical companies in developing and producing life-saving medications,
And the biggest growth area is palliative care.There is something more to be said. Pharma spends lots of money on political campaigns and the reward is that much of their research is paid for by the taxpayer, but never returned.
it's important to take a critical look at some of the industry practices that contribute to high drug prices and lack of accessibility for many patients. Here are some key points of concern:
To create a more equitable and accessible healthcare landscape, it's crucial to address these issues within the pharmaceutical industry. Policymakers, healthcare providers, and patient advocacy groups all have a role to play in advocating for greater transparency, fair pricing, and a more patient-centered approach to drug development and marketing.
- Profit-driven motives: The pharmaceutical industry is often driven primarily by profit, which can lead to a focus on developing drugs with the highest potential for financial gain rather than those that address the most pressing health needs. This can result in a lack of investment in treatments for rare diseases or those that predominantly affect low-income populations.
High drug prices: The high cost of many medications is a significant barrier to access for millions of people, particularly those without insurance or living in countries without robust healthcare systems. While companies need to recoup research and development costs, it's essential to find a balance that ensures fair profits without placing undue financial burdens on patients.
Patent abuse: Some pharmaceutical companies have been known to engage in "evergreening," a practice where minor modifications are made to existing drugs in order to extend their patent protection and keep prices high. This stifles competition from generic drug manufacturers and contributes to the high cost of medications.
Aggressive marketing tactics: The pharmaceutical industry often employs aggressive marketing strategies, targeting both doctors and patients, to promote the use of their products. This can lead to the over-prescription of drugs, particularly in cases where less expensive or less risky alternatives are available.
Opaque pricing: The lack of transparency in drug pricing makes it difficult for patients, healthcare providers, and policymakers to understand the true cost of medications and to negotiate fair prices.
Influence on research: The financial interests of pharmaceutical companies can sometimes influence research, leading to biased study designs, selective publication of positive results, and the suppression of negative findings.
And the argument about bias research goes way beyond pharma into the food companies which fund diabetes and nutrition authorities.
The result is that the dietary guidelines are false and particularly harmful, especially in the recommendations which persist to peddle fake vegetable oils and carbohydrates, which are the chief cause of obesity, diabetes heart disease, and now increasingly recognised as causing Alzheimer's.
sugar2.JPGsugar.JPG
The close relationship between industry and policymakers, as well as the significant financial resources at their disposal, can make it difficult to challenge these practices and promote more equitable, evidence-based healthcare policies. However, it's crucial for healthcare professionals, researchers, and the public to remain vigilant and advocate for greater transparency, unbiased research, and guidelines that prioritize public health over corporate profits.
To address these concerns, it's important to:
1. Encourage independent research and the replication of studies to ensure that scientific findings are valid and reliable.
2. Advocate for transparency in industry-funded research and the disclosure of potential conflicts of interest.
3. Promote the development of evidence-based dietary and healthcare guidelines that prioritize public health over industry interests.
4. Foster a critical approach to the consumption of information and the evaluation of research findings, particularly in the context of public health and nutrition.
5. Support policies that limit the influence of corporate interests on healthcare and public policy decision-making.
We have a food industry which has no concern for health and a health industry which has no concern for food.
Meanwhile nutritional advice is not only wrong, but dangerously causing harm. Even bodies like the Diabetic association of America is giving out advice likely to cause harm so as not to upset food producers.
It's also essential to engage in conversations with others and share information, as this can help raise awareness and promote critical thinking. In doing so, we can create a more empowered and informed public that is better equipped to hold corporations and policymakers accountable for their actions.
At the same time, we should advocate for policies that prioritize public health over corporate interests. This can involve supporting politicians who champion transparency and evidence-based decision-making, or even engaging in grassroots activism to bring about change.
Lastly, fostering a culture of empathy and compassion is vital. By understanding and respecting the needs and well-being of all living beings, we can work towards a more just and equitable society where the interests of the many are prioritized over the profits of the few.
– William James